Keyphrases
Working Diagnosis
100%
Follicular Lymphoma
100%
Progression-free Survival
13%
Relapsed or Refractory
13%
CREB1
13%
Mutation Burden
13%
Significantly mutated Genes
9%
Watch-and-wait
9%
POD24
9%
High Risk
4%
Non-associated
4%
Disease Progression
4%
Patient Outcomes
4%
Genetic Modification
4%
Newly Diagnosed
4%
Poor Prognosis
4%
Gene Set
4%
Leukemia
4%
Lymphoma
4%
Prognostic Value
4%
University of Washington
4%
SOCS1
4%
School of Medicine
4%
University Schools
4%
International Prognostic Index
4%
Tumor Protein p53 (TP53)
4%
Cleveland Clinic
4%
Myeloid Differentiation Factor 88 (MyD88)
4%
Risk of Progression
4%
Risk Subset
4%
Prompt Treatment
4%
Histologic Transformation
4%
Real-life Cohort
4%
IGLL5
4%
University of Miami
4%
Neuroscience
Mutated Genes
100%
Gene Mutation
50%
TP53
50%
STAT6
50%
MYD88
50%
Biochemistry, Genetics and Molecular Biology
Progression Free Survival
100%
Mutated Genes
66%
Gene Mutation
33%
STAT6
33%
MYD88
33%
Medicine and Dentistry
Follicular Lymphoma
100%
Progression Free Survival
13%
Malignant Neoplasm
4%
Medicine
4%
Gene Mutation
4%
STAT6 Protein
4%
Leukemia
4%
International Prognostic Index
4%
Diseases
4%
Pharmacology, Toxicology and Pharmaceutical Science
Follicular Lymphoma
100%
Progression Free Survival
13%
Malignant Neoplasm
4%
Leukemia
4%
STAT6 Protein
4%
Diseases
4%